Greenwich LifeSciences, Inc.

Contributing Author

Recent Articles by Greenwich LifeSciences, Inc.

Dec-29	Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 GLSI GlobeNewswire
Dec-22	Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy GLSI GlobeNewswire
Dec-15	Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 GLSI GlobeNewswire
Dec-08	Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 GLSI GlobeNewswire
Dec-03	Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date GLSI GlobeNewswire
Oct-09	Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial GLSI GlobeNewswire
Oct-02	Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium GLSI GlobeNewswire
Sep-30	Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial GLSI GlobeNewswire
Sep-18	Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland GLSI GlobeNewswire
Sep-10	Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track Designation GLSI GlobeNewswire
Aug-20	Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences GLSI GlobeNewswire
Aug-19	Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team GLSI GlobeNewswire
Aug-13	Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania GLSI GlobeNewswire
Aug-11	Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events GLSI GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.